Skip to main content

Advertisement

SpringerLink
Log in

The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review

Diabetic foot infections in Turkey

  • Review
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

The causative pathogens in diabetic foot infections differ in studies of European compared with Asian populations. The purpose of this study was to determine the causative microorganisms and their antibiotic sensitivity patterns in diabetic patients with a foot infection in Turkey, a country at the crossroads of these two continents. We performed a comprehensive literature search to identify all published studies pertaining to DFIs in patients cared for in Turkey. To assess changes in causative organisms and their antibiotic sensitivity patterns over time, we compared the results of just the most recent 5 years (2007–2011) with those of the past 20-years (1989–2011). We identified 31 studies meeting our inclusion criteria. Overall, these studies reported 2,097 patients, from whom 1,974 microorganisms were isolated. The total percentage of gram-negative and gram-positive aerobic bacteria were similar in each of the assessed periods. The rate of isolation of Staphylococcus aureus during the entire period, compared with just the past 5 years, was 23.8 % and 19.1 %, respectively, while the rate of methicillin-resistant S. aureus was 7.8 % and 5.7 %, respectively. The isolation rate of Pseudomonas aeruginosa was 13.7 % for the entire period and 14.9 % for the past 5 years. While linezolid, vancomycin and teicoplanin were the most active agents against gram-positive microorganisms, imipenem and cefoperazone-sulbactam were the most active against gram-negative microorganisms. This systematic review demonstrated few substantial changes in diabetic foot microbiology over the past 20 years. The data may help develop and update local clinical guidelines regarding antibiotic therapy for diabetic foot infections in Turkey. Further studies, especially with optimal culture methods, would be useful to validate these findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87(1):4–14. doi:10.1016/j.diabres.2009.10.007

    Article  CAS  PubMed  Google Scholar 

  2. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J (2005) The global burden of diabetic foot disease. Lancet 366(9498):1719–1724. doi:10.1016/S0140-6736(05)67698-2

    Article  PubMed  Google Scholar 

  3. van Battum P, Schaper N, Prompers L, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J, Ferreira I, Huijberts M (2011) Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabet Med 28(2):199–205. doi:10.1111/j.1464-5491.2010.03192.x

    Article  PubMed  Google Scholar 

  4. Tentolouris N, Jude EB, Smirnof I, Knowles EA, Boulton AJ (1999) Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med 16(9):767–771

    Article  CAS  PubMed  Google Scholar 

  5. Dang CN, Prasad YD, Boulton AJ, Jude EB (2003) Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 20(2):159–161. doi:10.1046/j.1464-5491.2003.00860.x

    Article  CAS  PubMed  Google Scholar 

  6. Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA (2007) Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 45(9):2819–2828. doi:10.1128/JCM.00551-07

    Article  PubMed Central  PubMed  Google Scholar 

  7. Ramakant P, Verma AK, Misra R, Prasad KN, Chand G, Mishra A, Agarwal G, Agarwal A, Mishra SK (2011) Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia 54(1):58–64. doi:10.1007/s00125-010-1893-7

    Article  CAS  PubMed  Google Scholar 

  8. Al Benwan K, Al Mulla A, Rotimi VO (2012) A study of the microbiology of diabetic foot infections in a teaching hospital in Kuwait. J Infect Public Health 5(1):1–8. doi:10.1016/j.jiph.2011.07.004]

    PubMed  Google Scholar 

  9. Mohanasoundaram KM (2012) The microbiological profile of diabetic foot infections. J Clin Diagn Res 6(3):409–411

    Google Scholar 

  10. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, Deery HG, Embil JM, Joseph WS, Karchmer AW, Pinzur MS, Senneville E (2012) Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 54(12):e132–173. doi:10.1093/cid/cis346

    Google Scholar 

  11. Umadevi S, Kumar S, Joseph NM, Easow JM, Kandhakumari G, Srirangaraj S, Raj S, Stephen S (2011) Microbiological study of diabetic foot infections. IJMS 2(1):12–17

    Google Scholar 

  12. Shanmugam P, Jeya M, Linda SS (2013) The bacteriology of diabetic foot ulcers, with a special reference to multidrug resistant strains. J Clin Diagn Res 7(3):441–445. doi:10.7860/JCDR/2013/5091.2794

    PubMed Central  PubMed  Google Scholar 

  13. Park SJ, Jung HJ, Shin HK, Kim E, Lim JJ, Yoon JW (2009) Microbiology and antibiotic selection for diabetic foot infections. J Korean Foot Ankle Soc 13(2):150–155

    Google Scholar 

  14. Carvalho CB, Neto RM, Aragao LP, Oliveira MM, Nogueira MB, Forti AC (2004) Pe diabetico: analise bacteriologica de 141 casos (Diabetic foot infection. Bacteriologic analysis of 141 patients.). Arq Bras Endocrinol Metabol 48(3):398–405

    Article  PubMed  Google Scholar 

  15. Dezfulian A, Salehian MT, Amini V, Dabiri H, Azimi Rad M, Aslani MM, Alebouyeh M, Fazel I, Zali MR (2011) Bacteriological study of diabetic foot infections in an Iranian hospital. Iran Red Crescent Med J 13(8):590–591

    CAS  PubMed Central  PubMed  Google Scholar 

  16. Mendes JJ, Marques-Costa A, Vilela C, Neves J, Candeias N, Cavaco-Silva P, Melo-Cristino J (2012) Clinical and bacteriological survey of diabetic foot infections in Lisbon. Diabetes Res Clin Pract 95(1):153–161. doi:10.1016/j.diabres.2011.10.001

    Article  CAS  PubMed  Google Scholar 

  17. Lipsky BA, Holroyd KJ, Zasloff M (2008) Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin Infect Dis 47(12):1537–1545. doi:10.1086/593185

    Article  PubMed  Google Scholar 

  18. Kandemir O, Akbay E, Sahin E, Milcan A, Gen R (2007) Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms. J Infect 54(5):439–445. doi:10.1016/j.jinf.2006.08.013

    Article  PubMed  Google Scholar 

  19. Richard JL, Sotto A, Jourdan N, Combescure C, Vannereau D, Rodier M, Lavigne JP (2008) Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers. Diabetes Metab 34(4 Pt 1):363–369. doi:10.1016/j.diabet.2008.02.005

    Article  PubMed  Google Scholar 

  20. Ertugrul BM, Oncul O, Tulek N, Willke A, Sacar S, Tunccan OG, Yilmaz E, Kaya O, Ozturk B, Turhan O, Yapar N, Ture M, Akin F (2012) A prospective, multi-center study: factors related to the management of diabetic foot infections. Eur J Clin Microbiol Infect Dis 31(9):2345–2352. doi:10.1007/s10096-012-1574-1

    Article  CAS  PubMed  Google Scholar 

  21. Bakker K, Apelqvist J, Schaper NC (2012) Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev 28(Suppl 1):225–231. doi:10.1002/dmrr.2253

    Article  PubMed  Google Scholar 

  22. Bakker K, Schaper NC (2012) The development of global consensus guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev 28(Suppl 1):116–118. doi:10.1002/dmrr.2254

    Article  PubMed  Google Scholar 

  23. Lipsky BA, Peters EJ, Berendt AR, Senneville E, Bakker K, Embil JM, Lavery LA, Urbancic-Rovan V, Jeffcoate WJ (2012) Specific guidelines for the treatment of diabetic foot infections 2011. Diabetes Metab Res Rev 28(Suppl 1):234–235. doi:10.1002/dmrr.2251

    Article  PubMed  Google Scholar 

  24. Blanes JI (2011) Consensus document on treatment of infections in diabetic foot. Rev Esp Quimioter 24(4):233–262

    PubMed  Google Scholar 

  25. Tan T, Shaw EJ, Siddiqui F, Kandaswamy P, Barry PW, Baker M (2011) Inpatient management of diabetic foot problems: summary of NICE guidance. BMJ 342:d1280. doi:10.1136/bmj.d1280

    Article  CAS  PubMed  Google Scholar 

  26. Société de Pathologie Infectieuse de Langue Française (2007) Management of diabetic foot infections. Long text. Med Mal Infect 37 (1):26–50

    Google Scholar 

  27. Moher D, Liberati A, Tetzlaff J, Altman DG (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336–341. doi:10.1016/j.ijsu.2010.02.007

    Article  PubMed  Google Scholar 

  28. Akova M, Ozcebe O, Gullu I, Unal S, Gur D, Akalin S, Tokgozoglu M, Telatar F, Akalin HE (1996) Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections. J Chemother 8(4):284–289

    Article  CAS  PubMed  Google Scholar 

  29. Gökel Y (1996) Diyabetik ayak enfeksiyonlarında etyoloji, tedavi ve prognoz (in Turkish). Çukurova University, Adana

    Google Scholar 

  30. Tarhan O, Aker Aİ, Hekimsoy Z, Çömlekçi A, Okan İ, Biberoğlu S, Yeşil S, Araç S, Oto Ö, Gülay Z, Biberoğlu K (1997) Diabetic extremity infections: our clinical experiences. FLORA 3:183–187

    Google Scholar 

  31. Gökalan IK, Çetin B, Yalçın N, Sermez Y (1999) Conservative treatment of diabetic foot infections. Le Infezioni in Medicina 1:39–42

    Google Scholar 

  32. Ulusoy S, Arda B, Bayraktar F, Sesli E, Özinel MA, Yamazhan T, Ünal İ, Kısakol G, Tüzün M (2000) Diabetic foot infections: the evaluation of 179 cases. FLORA 5(4):220–228

    Google Scholar 

  33. Kandemir Ö, Öztuna V, Şahin E, Eskandari MM, Kaya A (2002) Assessment of the severe diabetic foot infections with respect to aerobic microorganisms and clinical aspects. ANKEM Derg 16(4):466–469

    Google Scholar 

  34. Arıkan Ş, Karaahmetoğlu S, Müftüoğlu O (2002) Are increases of fever, white blood cell and erytrocyte sedimentation rate as an indicator for poor prognosis in patients with diabetic foot? Türkiye Tıp Dergisi 9(2):49–54

    Google Scholar 

  35. Uzun G, Solmazgul E, Curuksulu H, Turhan V, Ardic N, Top C, Yildiz S, Cimsit M (2007) Procalcitonin as a diagnostic aid in diabetic foot infections. Tohoku J Exp Med 213 (4):305–312. doi:JST.JSTAGE/tjem/213.305.

    Google Scholar 

  36. Ozkara A, Delibası T, Selcoki Y, Arikan MF (2008) The major clinical outcomes of diabetic foot infections: One center experience. Cent Eur J Med 3(4):464–469

    Article  Google Scholar 

  37. Bezirgan S (2010) Diyabetik ayakta enfeksiyon etkenleri ve antibiyotik duyarlılıkları (in Turkish). Kocaeli University, Kocaeli

    Google Scholar 

  38. Mert G, Metin S, Yýldýz E, Karakuzu E, Çakmak T (2012) Infection agents detected with wound culture in patients with diabetic foot who will undergo hyperbaric oxygen treatment. TAF Prev Med Bull 11(2):205–210

    Google Scholar 

  39. Ata N (2009) The importance of risk factors and microbiological diagnosis in the treatment of diabetic foot infections. Gazi University, Ankara

    Google Scholar 

  40. Örmen B, Türker N, Vardar İ, Coşkun NA, Kaptan F, Ural S, El S, Türker M (2007) Clinical and bacteriological analysis of diabetic foot infections. İnfeksiyon Dergisi (Turkish Journal of Infection) 21(2):65–69

    Google Scholar 

  41. Gündeş S, Yuluğkural Z, Cantürk Z, Bıyıklı M, Çetinarslan B (2007) Evaluation of a diabetic foot protocol: clinical and microbiological data of 68 diabetic patients with deep foot infections, treatment and prognosis. Hastane İnfeksiyonları Dergisi 11(4):246–251

    Google Scholar 

  42. Öztoprak N, Akduman D, Pişkin N, Çelebi G, Aydemir H (2007) Diabetic foot infections: the evaluation of 35 cases. FLORA 12(4):196–200

    Google Scholar 

  43. Şerefhanoğlu K, Turan H, Ergin TF, Arslan H (2006) Aerobic bacteriological analysis of diabetic foot infections. ANKEM Derg 20(2):85–88

    Google Scholar 

  44. Demirci H, Aktürk M, Günal Ö, Güler MÖ, Kandal S, Güner H, Karakoç A, Törüner FB, Arslan M (2006) Microorganisms that cause the infections in diabetic foot patients. MN Dahili Tıp Bilimleri 1(2):85–89

    Google Scholar 

  45. Özaydin Ç, Özaydin I, Acar S, Yavuz TM, Öksüz Ş, Şahin I, Yildirim M, Karaman S (2010) Clinical and aerobic bacteriological analysis of diabetic foot infections. Türk Mikrobiyol Cem Derg 40(2):109–116

    Google Scholar 

  46. Saçar S, Turgut H, Kaleli İ, Toprak S, Demir M, Cenger DH (2008) Pamukkale Üniversitesi Hastanesi’nde diyabetik ayak infeksiyonlarının mikrobiyolojik ve klinik degerlendirmesi. Pamukkale Tıp Dergisi 1:9–12

    Google Scholar 

  47. Açar GK (2006) Diabetik ayakta tedavi yaklaşımları ve wagner sınıflamasının tedaviyi yönlendirmedeki rolü (in Turkish). İstanbul Medeniyet University, İstanbul

    Google Scholar 

  48. Cetin M, Ocak S, Kuvandik G, Aslan B (2007) Comparison of bacterial isolates cultured from hemodialysis patients and other patients with diabetic foot and their antimicrobial resistance. Ren Fail 29(8):973–978. doi:10.1080/08860220701641702

    Article  CAS  PubMed  Google Scholar 

  49. Ertugrul MB, Baktiroglu S, Salman S, Unal S, Aksoy M, Berberoglu K, Calangu S (2008) Pathogens isolated from deep soft tissue and bone in patients with diabetic foot infections. J Am Podiatr Med Assoc 98(4):290–295

    Article  PubMed  Google Scholar 

  50. Ozer B, Kalaci A, Semerci E, Duran N, Davul S, Yanat AN (2010) Infections and aerobic bacterial pathogens in diabetic foot. Afr J Microbiol Res 4(20):2153–2160

    Google Scholar 

  51. Bozkurt F, Gülsün S, Tekin R, Hosoglu S, Acemoglu H (2011) Comparison of microbiological results of deep tissue biopsy and superficial swab in diabetic foot infections. J Microbiol Infect Dis 1(3):122–127

    Article  Google Scholar 

  52. Saltoglu N, Dalkiran A, Tetiker T, Bayram H, Tasova Y, Dalay C, Sert M (2010) Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital. Clin Microbiol Infect 16(8):1252–1257. doi:10.1111/j.1469-0691.2009.03067.x

    CAS  PubMed  Google Scholar 

  53. Altay FA, Sencan I, Senturk GC, Altay M, Guvenman S, Unverdi S, Acikgoz ZC (2012) Does treatment affect the levels of serum interleukin-6, interleukin-8 and procalcitonin in diabetic foot infection? A pilot study. J Diabetes Complicat 26(3):214–218. doi:10.1016/j.jdiacomp.2012.03.018

    Article  PubMed  Google Scholar 

  54. Gönen MS, Çakır M, Gönülalan G, Öztürk M, İpekçi SH, Köşker A, Karalezli MN, Erayman I, Durgul K, Keskin M, Seyhan N (2012) The problems and cost-effectiveness analysis of diabetic foot infections. Turk Jem 16:10–13

    Google Scholar 

  55. Akçay S, Satoğlu İS, Harman E, Kurtulmuş A, Kazımoğlu C (2012) A retrospective analysis of amputation rates and comorbidity in patients with diabetic foot ulcer. Med-Science 1(4):331–340

    Google Scholar 

  56. Mutluoglu M, Uzun G, Turhan V, Gorenek L, Ay H, Lipsky BA (2012) How reliable are cultures of specimens from superficial swabs compared with those of deep tissue in patients with diabetic foot ulcers? J Diabetes Complicat 26(3):225–229. doi:10.1016/j.jdiacomp.2012.03.015

    Article  PubMed  Google Scholar 

  57. Raja NS (2007) Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases. J Microbiol Immunol Infect 40(1):39–44

    PubMed  Google Scholar 

  58. Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R (2006) A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 29(8):1727–1732. doi:10.2337/dc06-0116

    Article  PubMed  Google Scholar 

  59. Lipsky BA (2004) Medical treatment of diabetic foot infections. Clin Infect Dis 39(Suppl 2):S104–S114. doi:10.1086/383271

    Article  PubMed  Google Scholar 

  60. Giordano P, Song J, Pertel P, Herrington J, Kowalsky S (2005) Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection. Int J Antimicrob Agents 26(5):357–365. doi:10.1016/j.ijantimicag.2005.07.017

    Article  CAS  PubMed  Google Scholar 

  61. Eleftheriadou I, Tentolouris N, Argiana V, Jude E, Boulton AJ (2010) Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs 70(14):1785–1797. doi:10.2165/11538070-000000000-00000

    Article  CAS  PubMed  Google Scholar 

  62. Erdem H, Dizbay M, Karabey S, Kaya S, Demirdal T, Koksal I, Inan A, Erayman I, Ak O, Ulu-Kilic A, Karasahin O, Akbulut A, Elaldi N, Yilmaz G, Candevir A, Gul HC, Gonen I, Oncul O, Aslan T, Azak E, Tekin R, Kocak Tufan Z, Yenilmez E, Arda B, Gungor G, Cetin B, Kose S, Turan H, Akalin H, Karabay O, Dogan-Celik A, Albayrak A, Guven T, Celebi G, Ozgunes N, Ersoy Y, Sirmatel F, Oztoprak N, Balkan II, Bayazit FN, Ucmak H, Oncu S, Ozdemir D, Ozturk-Engin D, Bitirgen M, Tabak F, Akata F, Willke A, Gorenek L, Ahmed SS, Tasova Y, Ulcay A, Dayan S, Esen S, Leblebicioglu H, Altun B, Unal S (2013) Withdrawal of Staphylococcus aureus from intensive care units in Turkey. Am J Infect Control 41(11):1053–1058. doi:10.1016/j.ajic.2013.01.041

    Article  PubMed  Google Scholar 

  63. Noel GJ, Bush K, Bagchi P, Ianus J, Strauss RS (2008) A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections. Clin Infect Dis 46(5):647–655. doi:10.1086/526527

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Infectious Diseases and Clinical Microbiology, Gulhane Military Medical Academy, Haydarpasa Teaching Hospital, 34668, Uskudar, Istanbul, Turkey

    M. Hatipoglu & V. Turhan

  2. Department of Underwater and Hyperbaric Medicine, Gulhane Military Medical Academy, Haydarpasa Teaching Hospital, 34668, Uskudar, Istanbul, Turkey

    M. Mutluoglu

  3. Department of Underwater and Hyperbaric Medicine, Gulhane Medical Academy, Ankara, Turkey

    G. Uzun

  4. Department of Dermatology, Gulhane Military Medical Academy, Haydarpasa Teaching Hospital, 34668, Uskudar, Istanbul, Turkey

    E. Karabacak

  5. Department of Medicine, University of Geneva, Geneva, Switzerland

    B. A. Lipsky

  6. Division of Medical Sciences, University of Oxford, Oxford, UK

    B. A. Lipsky

Authors
  1. M. Hatipoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Mutluoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Uzun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Karabacak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Turhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. A. Lipsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Mutluoglu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hatipoglu, M., Mutluoglu, M., Uzun, G. et al. The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review. Eur J Clin Microbiol Infect Dis 33, 871–878 (2014). https://doi.org/10.1007/s10096-014-2047-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-014-2047-5

Keywords

Search

Navigation